We are a state of art, basic science-driven biotech company established in 2020 to help patients sustain the joy of living healthy and long. Management team of Bycus consists of domain experts with several years of experience in clone development, upstream and downstream bioprocess, quality control, and regulatory landscape. This gives us a competitive edge in increasing the success rate of products development with shorter timelines.
We collaborate with our academic and industry partners to translate discoveries and manufacture new products. We are one of the fastest-growing biotech Company, with a vision to increase the affordability and standard of medical care by developing low-cost and high-quality drug substances and products that support the supply chain of other companies with the core values of integrity and a patient-first approach.